Hence, ARHGAP11B fulfills a key criterion for its potential therapeutic application in neuron replenishment strategies for the treatment of neurodegenerative diseases—the ability to induce in vivo the self-renewal of those progenitor cells that generate cortical neurons. This evidence concerns the gene ARHGAP11B and neurodegenerative disease.